The KLOW dosage protocol guide isn't just a set of instructions
A 2025 systematic review and meta-analysis published on PubMed found that GLP-1 RAs were superior to placebo in reducing AHI in patients with OSA and obesity, with additional benefits including reduced body weight, lower blood pressure, and improved cardiometabolic risk markers
In the worst-case scenario, contaminated injectables can cause serious infections or other health crises that require immediate medical attention
It is not intended for human or animal consumption, injection, diagnosis, treatment, or therapeutic use
That observation points to a potential inflection in access and affordability that could distinguish Foundayo from semaglutide-based options in the years ahead
Two research stories that never actually meet